Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60

201880 citationsJournal Article

Authors

Le H. Hua · Lou Ruvo Brain Institute

Tracey Fan · Touro University Nevada

Devon Conway · Cleveland Clinic

Nicolas R. Thompson · Cleveland Clinic

Tyler G. Kinzy · Cleveland Clinic

Abstract

Most patients over age 60, who discontinued DMT, remained off DMT. This study provides real-world data that may guide clinicians considering discontinuing DMT.

Topics & Keywords

Multiple Sclerosis Research Studies Autoimmune and Inflammatory Disorders Research Rheumatoid Arthritis Research and Therapies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Multiple Sclerosis Journal

Volume 25, Issue 5, pp. 699-708

DOI: 10.1177/1352458518765656

Field-Weighted Citation Impact: 5.33